What new US cholesterol guidelines mean for statin eligibility

Key Points:

• Updated 2026 cholesterol treatment guidelines could make an estimated 21.5 million more U.S. adults eligible for statins, increasing total eligibility to about 87.5 million people, or nearly 57% of adults aged 30 to 79.
• The expanded eligibility results from four key changes: lowering the age range for risk assessment to 30-79 years, reducing cardiovascular risk thresholds, giving more weight to conditions like advanced kidney disease and HIV, and emphasizing long-term (30-year) risk.
• Eligibility does not mandate starting statins; decisions should be individualized based on factors such as age, risk level, medical history, and personal preferences, with high-risk individuals more strongly encouraged to consider treatment.
• Patients are advised to discuss their cholesterol levels, overall cardiovascular risk, potential benefits, side effects, and monitoring plans with healthcare providers, who may use tools like the AHA’s PREVENT calculator and additional tests such as coronary artery calcium scans.
• Lifestyle changes remain crucial for all, including healthy diet, exercise, weight management, and smoking cessation, and may be the first step for some before considering medication, especially those with moderate risk.